Previous Article | Next Article 
Journal of Clinical Microbiology, October 2006, p. 3616-3622, Vol. 44, No. 10
0095-1137/06/$08.00+0 doi:10.1128/JCM.01187-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Comparison of Three Commercial Assays and a Modified Disk Diffusion Assay with Two Broth Microdilution Reference Assays for Testing Zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with Posaconazole and Amphotericin B
A. Espinel-Ingroff*
Division of Infectious Diseases, VCU Medical Center, Richmond, Virginia 23298-0049
Received 8 June 2006/
Returned for modification 24 July 2006/
Accepted 10 August 2006
We compared posaconazole M27-A2 and M38-A MICs to Etest and YeastOne MICs for 92 zygomycetes, 126 Aspergillus isolates, 110 Candida isolates, and Cryptococcus neoformans. Reference MICs were also correlated with inhibition zone diameters in millimeters (modified M44-A disk and Neo-Sensitabs tablet methods). Etest MICs were obtained on solidified (1.5% agar) RPMI 1640 (2% dextrose), and zone diameters were obtained on supplemented (2% glucose and 0.5 µg/ml methylene blue [for all isolates]) and nonsupplemented Mueller-Hinton (MH; molds only) agar. MICs and zone diameters were obtained between 16 and 72 h. The overall agreement (% MIC pairs within a three-dilution range) between reference posaconazole and YeastOne MICs was 98 to 100% at 16 to 24 h for zygomycetes and yeasts and 99% at 24 to 48 h for Aspergillus. The overall agreement was lower between reference posaconazole and Etest MICs (94 to 97%) and by both methods with amphotericin B for all species (95 to 99.3%). For yeasts, the correlation coefficient was similar between reference posaconazole MICs and either disk (R, 0.810) or tablet (R, 0.769) zone diameter at 24 h and was superior on MH agar for molds at 16 to 48 h (R, 0.804 and 0.799 for disk and tablet, respectively). For amphotericin B, the best correlation between reference MICs and zone diameters was observed at 16 to 48 h for molds on MH agar (R, 0.736 to 0.812 and 0.765 to 0.749 for disk and tablet, respectively) and at 48 h for yeasts (R, 0.681 and 0.503 for disk and tablet, respectively). These data suggest the potential value of these alternative broth dilution and agar diffusion methods for testing posaconazole and amphotericin B in the clinical laboratory against the species evaluated.
* Division of Infectious Diseases, VCU Medical Center, 1101 East Marshall St., Sanger Hall Room 7-049, Richmond, VA 23298-0049. Phone: (804) 828-5743. Fax: (804) 828-3097. E-mail:
avingrof{at}vcu.edu.
Published ahead of print on 30 August 2006.
Journal of Clinical Microbiology, October 2006, p. 3616-3622, Vol. 44, No. 10
0095-1137/06/$08.00+0 doi:10.1128/JCM.01187-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Espinel-Ingroff, A., Canton, E.
(2008). Comparison of Neo-Sensitabs Tablet Diffusion Assay with CLSI Broth Microdilution M38-A and Disk Diffusion Methods for Testing Susceptibility of Filamentous Fungi with Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole. J. Clin. Microbiol.
46: 1793-1803
[Abstract]
[Full Text]
-
Canton, E., Peman, J., Espinel-Ingroff, A., Martin-Mazuelos, E., Carrillo-Munoz, A., Martinez, J. P.
(2008). Comparison of disc diffusion assay with the CLSI reference method (M27-A2) for testing in vitro posaconazole activity against common and uncommon yeasts. J Antimicrob Chemother
61: 135-138
[Abstract]
[Full Text]
-
Almyroudis, N. G., Sutton, D. A., Fothergill, A. W., Rinaldi, M. G., Kusne, S.
(2007). In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents. Antimicrob. Agents Chemother.
51: 2587-2590
[Abstract]
[Full Text]
-
Espinel-Ingroff, A., Arthington-Skaggs, B., Iqbal, N., Ellis, D., Pfaller, M. A., Messer, S., Rinaldi, M., Fothergill, A., Gibbs, D. L., Wang, A.
(2007). Multicenter Evaluation of a New Disk Agar Diffusion Method for Susceptibility Testing of Filamentous Fungi with Voriconazole, Posaconazole, Itraconazole, Amphotericin B, and Caspofungin. J. Clin. Microbiol.
45: 1811-1820
[Abstract]
[Full Text]
-
Messer, S. A., Diekema, D. J., Hollis, R. J., Boyken, L. B., Tendolkar, S., Kroeger, J., Pfaller, M. A.
(2007). Evaluation of Disk Diffusion and Etest Compared to Broth Microdilution for Antifungal Susceptibility Testing of Posaconazole against Clinical Isolates of Filamentous Fungi. J. Clin. Microbiol.
45: 1322-1324
[Abstract]
[Full Text]
-
Espinel-Ingroff, A., Canton, E., Gibbs, D., Wang, A.
(2007). Correlation of Neo-Sensitabs Tablet Diffusion Assay Results on Three Different Agar Media with CLSI Broth Microdilution M27-A2 and Disk Diffusion M44-A Results for Testing Susceptibilities of Candida spp. and Cryptococcus neoformans to Amphotericin B, Caspofungin, Fluconazole, Itraconazole, and Voriconazole. J. Clin. Microbiol.
45: 858-864
[Abstract]
[Full Text]
-
Torres-Narbona, M., Guinea, J., Martinez-Alarcon, J., Pelaez, T., Bouza, E.
(2007). In Vitro Activities of Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole against 45 Clinical Isolates of Zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the Etest. Antimicrob. Agents Chemother.
51: 1126-1129
[Abstract]
[Full Text]